These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11824001)
1. Mega-trials and equivalence trials: experience from the INJECT study. Hampton JR Eur Heart J; 1996 Sep; 17 Suppl E():28-34. PubMed ID: 11824001 [TBL] [Abstract][Full Text] [Related]
2. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics. Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530 [TBL] [Abstract][Full Text] [Related]
3. Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Noble S; McTavish D Drugs; 1996 Oct; 52(4):589-605. PubMed ID: 8891469 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials in thrombolytic therapy: what do they tell us? INJECT 6-month outcomes data. Wilcox RG Am J Cardiol; 1996 Dec; 78(12A):20-3. PubMed ID: 8990407 [TBL] [Abstract][Full Text] [Related]
5. Evidence-based medicine and reteplase: inductive arguments over deductive reasoning. Massel D Can J Cardiol; 1999 Sep; 15(9):999-1005. PubMed ID: 10504181 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review. Dundar Y; Hill R; Dickson R; Walley T QJM; 2003 Feb; 96(2):103-13. PubMed ID: 12589008 [TBL] [Abstract][Full Text] [Related]
8. Spotlight on reteplase in thrombotic occlusive disorders. Simpson D; Siddiqui MA; Scott LJ; Hilleman DE BioDrugs; 2007; 21(1):65-8. PubMed ID: 17263591 [TBL] [Abstract][Full Text] [Related]
9. Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial. Topol EJ; Ohman EM; Armstrong PW; Wilcox R; Skene AM; Aylward P; Simes J; Dalby A; Betriu A; Bode C; White HD; Hochman JS; Emanuelson H; Vahanian A; Sapp S; Stebbins A; Moliterno DJ; Califf RM Circulation; 2000 Oct; 102(15):1761-5. PubMed ID: 11023929 [TBL] [Abstract][Full Text] [Related]
10. Controlled trials comparing reteplase with alteplase and streptokinase in patients with acute myocardial infarction. Amsterdam EA Pharmacotherapy; 1996; 16(5 Pt 2):137S-140S. PubMed ID: 8888101 [TBL] [Abstract][Full Text] [Related]
11. Reteplase: a review of its use in the management of thrombotic occlusive disorders. Simpson D; Siddiqui MA; Scott LJ; Hilleman DE Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828 [TBL] [Abstract][Full Text] [Related]
12. The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials. Weaver WD Eur Heart J; 1996 Dec; 17 Suppl F():9-15. PubMed ID: 8960443 [TBL] [Abstract][Full Text] [Related]
14. A comparison of reteplase with alteplase for acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503 [TBL] [Abstract][Full Text] [Related]